Cervical cerclage for preventing premature birth in high-risk pregnancies
Official title: Cervical Cerclage for Short Cervix at 24-26 Weeks of Gestation: a Randomized Controlled Trial
Run by Thomas Jefferson University · NCT06036446 · Data updated 2026-11-12
This study is testing if a procedure called cervical cerclage can help prevent early birth in pregnant people who are at high risk due to a short cervix.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 329 (estimated) |
| Sponsor | Thomas Jefferson University Academic / other |
| Locations | 2 sites (Charlotte, North Carolina and 1 other locations) |
| Status | Recruiting |
| Started | November 10, 2023 |
| Main results expected | October 2028 |
| Study ends | February 2029 |
| Registry record updated | May 29, 2026 |
| Trial ID | NCT06036446 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant individuals aged 18-50 with singleton pregnancies and a cervical length of 25mm or less between 24 and 26 weeks of gestation.
✕Probably not a fit
Patients with multifetal pregnancies, active preterm labor, or other contraindications to cerclage placement may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of cervical cerclage in reducing the risk of preterm birth among singleton pregnancies identified as high-risk due to a short cervical length of 25mm or less. Pregnant individuals between 24 and 26 weeks of gestation will be screened and randomized to receive either cervical cerclage or no cerclage, while all participants will also be recommended to use vaginal progesterone. The primary outcome measured will be the incidence of preterm birth before 37 weeks of gestation. This approach seeks to provide a potential intervention for those at significant risk of early delivery.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the incidence of preterm births in high-risk pregnancies.
How similar studies have gone: Previous studies have shown varying degrees of success with cervical cerclage in preventing preterm birth, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-50 years old, pregnant, assigned female at birth * Singleton pregnancy * TVU CL ≤25mm between 24 0/7 - 26 6/7 weeks of gestation Exclusion Criteria: * Initial multifetal gestation with subsequent multifetal pregnancy reduction, or selective fetal termination performed \>14 weeks, or cotwin pregnancy loss diagnosed \>14 weeks * Cerclage in situ * Preterm labor, defined as painful regular uterine contractions and change in cervical dilation * PPROM * Active vaginal bleeding * Suspected intraamniotic infection * Major fetal structural abnormality or chromosomal disorder * Placenta previa or accreta * Other contraindication to cerclage placement * Participation in another clinical trial related to preterm birth prevention, cerclage, or progesterone
Where it's running
-
Atrium Health Carolinas Medical Center
Charlotte, North Carolina, United States Recruiting -
Thomas Jefferson University
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Moti Gulersen, MD, MSc — Thomas Jefferson University
- Study coordinator: Moti Gulersen, MD, MSc
- Email: moti.gulersen@jefferson.edu
- Phone: 215-955-5000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Wireless MicroPremVitals Button Sensor for the NICU
This study tests a tiny wireless sensor system to monitor heart rate, oxygen, and temperature in extremely preterm babies in the NICU to see if it works safely without wires.
-
Caffeine in pregnancy: how the mother and baby handle it during delivery
This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.
-
Neonatal data and biobank to understand what influences development in very preterm infants
This project will collect clinical information and biological samples to see if early biological, clinical, and environmental factors predict short- and long-term development in infants born before 32 weeks or under 1500 g.
-
Biomarkers in infants with prior neonatal brain injury
This project will test brain activity and development using games, EEG, and parent questionnaires in infants aged 3–24 months with and without prior neonatal brain injury.
-
PIOMI plus time‑based feeding to help preterm babies start oral feeds and gain weight
We will test whether a specific oral‑motor routine (PIOMI) and a time‑based (chronobiological) feeding approach help preterm infants born at 29–33 weeks begin oral feeding sooner and gain weight better.
-
Home air purifier to support lung recovery in babies born prematurely
This tests whether using an air purifier at home improves breathing and oxygen levels in babies who were born prematurely.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.